We are starting a new poll, suggested by JohninKent, about whether herceptin was offered during treatment. Here is what John says:
Trastuzumab, or Herceptin was approved by NICE in November 2011. This is a drug that was developed for breast cancer but passed the value for money criteria to be approved for stage 4 metastatic GI cancers if they tested positive for HER2. Initially very few people were given it because they did not know of it and worse neither did their doctors. It is proven to be effective and prolongs life and patients should automatically be tested. A survey published a few weeks ago said that a large percentage of doctors were not routinely conducting tests for the best treatments for cancers in general and I wondered how this applied to EC but the main reason is to make sure people are aware that this treatment is available. This is especially important for people who have metastatic cancer and also for people like yourself who are approached for advice and guidance. I have plenty of anecdotal evidence that it is not routinely offered. I was only given the test after asking for it and my cancer was found suitable for treatment. This applies to about 25%. Again anecdotal evidence shows the situation is improving. So that is what I am trying to do, ensure that patients and supporters like yourself are aware of Herceptin.